AzTrials
AzTrials

Sedentary LifestyleNCT03212859

Coach2Move: Sustainable in Daily Practice

A study testing Coach2Move in people with Sedentary Lifestyle and Physical Activity, run by Radboud University Medical Center at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Implementation of a previously shown (cost-)effective physical therapeutic treatment strategy for community-dwelling older adults. Read more about this study

Who is it for?
Ages 70 years and older
What is being tested?
Coach2Move
Could I receive a placebo?
No, everyone receives an active treatment
How many people
292 participants
Where
1 siteNetherlands
Study dates
6 Nov 2017to 4 Sep 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Aged 70 years or older
  • Community-dwelling
  • mobility related problems or problems related to activities of daily living
  • sedentary lifestyle or are at risk of losing an active lifestyle

Who cannot join

  • Patients who are not ambulatory after treatment and/or are in palliative phase.
  • Patients who are indicated to become institutionalised in the near future.

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Ward Heij

    Nijmegen, Gelderland, 6500 HB, PO. 9101

Other trials in Netherlands

About this study

Implementation of a previously shown (cost-)effective physical therapeutic treatment strategy for community-dwelling older adults.

Read the detailed description

In a previous trial, researchers demonstrated that the Coach2Move approach is superior to regular physiotherapy in terms of increasing physical activity, reducing frailty, improving quality of life and reducing healthcare costs. In short, in less physiotherapeutic sessions, better outcomes were realized.

Despite these promising findings, the research group still has questions regarding the generalisability of these findings. The reservations towards the generalisability of the approach are caused by the following:

  1. A modest (n=130), yet somewhat selective study sample was included: nearly half of the eligible individuals declined randomisation and thereby participation. An understanding is needed how this group of eligible non volunteers respond to Coach2Move. Therefore, a study design that avoids randomisation at the patient level will be used.
  2. The Coach2Move approach significantly increased the level of moderate physical activity among the treatment group and reduced levels of frailty significantly after 6 months, but the clinical importance of these findings is still unclear. Thus, a replication of the effects in the light of physical functioning is needed in a larger more variable study population and with a longer follow-up.

In addition, the results from the earlier carried out RCT concerning the cost-effectiveness of Coach2Move have to be replicated on a larger scale.

For the reasons mentioned above, it is important to further implement Coach2Move and study its effect, costs, and feasibility in current practice. A stepped wedge cluster randomised trial design is chosen because in the opinion of the researchers, the implementation strategy will do more good than harm (making a parallel design, in which certain practices do not receive the intervention or to withdraw the intervention as would occur in a cross-over design, is unethical) and it furthermore minimizes contamination.

The objective of this study is to assess the cost-effectiveness of the implementation of a patient and context focused tailored coaching intervention (Coach2Move) in the daily physiotherapy practice for older adults with mobility problems compared to usual physiotherapy. The hypothesis is that Coach2Move leads to better physical outcomes and lower costs than usual care.

Being tested
Coach2Move, Usual Care
Keywords
older adults, physiotherapy, physical activity
Medical subject headings
Sedentary Behavior, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Coach2MoveBehavioural

    Coach2Move is a multicomponent physiotherapeutic approach in addition to usual care physiotherapy consisting of:

    • Extensive intake during which not only impairments and disabilities, but wishes, barriers and facilitators considering physical functioning are profoundly examined.
    • Motivational interviewing is used to find and deal with barriers for becoming physically active and shared-decision making in goal setting.
    • The approach is patient focused (tailor made) and goal-oriented: the physiotherapist coaches the patient and the environment in reaching and maintaining their own goals.
    • In consultation with the patient, a stratified intervention is chosen by picking the best fitting option out of three patient-tailored intervention profiles with a predefined number of intervention sessions.
  • Usual CareBehavioural

    Usual care physiotherapy among older adults:

    • Intake of 30 minutes consisting of examining medical history, physical functioning and functional exercises to assess the demand for care.
    • Use of treatment modalities to enhance physical functioning (strength, mobility, coordination, balance etc.)
    • Consultation and advisory role in relation to the functional status of geriatric patients and his/her relations.
    • Collaborate with other disciplines in a multidisciplinary context.
Study groups in NCT03212859
Study groupRoleWhat they receive
Coach2Move Intervention GroupExperimentalCoach2Move Intervention Group
Receives: Behavioral: Coach2Move
Usual CareActive comparatorUsual care physiotherapy among older adults
Receives: Behavioral: Usual Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-reported Physical Activity

    The primary outcome of the study is physical activity measured by the LAPAQ questionnaire, subscale moderate activity. This subscale of the LAPAQ is a comprehensive questionnaire on diverse (physical) activities of daily living with moderate intensity including walking, riding a bicycle etc. and is specifically designed to assess habitual physical activity of the elderly.

    Measured: 27 months

  2. Functional Mobility

    The key secondary outcome is functional mobility as measured by the Timed Up and Go test.

    Measured: 27 months

Secondary outcomes (4)
  1. Functional Status

    The Patient Specific Complaints Scale is used to measure the functional status of a patient. The patients select 3-5 most important mobility problems in daily life and are the most important goals to improve. The degree of hinder is scored by the patient on a 10-point numeric scale.

    Measured: 12 months

  2. Cost effectiveness

    The direct costs of regular physiotherapy and Coach2Move will be determined on a per patient basis. On patient level, volumes of care will be measured prospectively using medical records and cost questionnaires.

    Next will be determining the cost prices for each volume of consumption in order to use these for the volumes registered for each participating patient.

    Both outcome measures will be aggregated to one reported value (cost per volume x volumes used). A comparison in costs will be made between the Coach2Move and usual care groups.

    Measured: 27 months

  3. Patient Satisfaction

    The Global Perceived Satisfaction and Effect score is used to measure the patients' satisfaction about the intervention and the perceived effect on a 7-point Likert scale ranging from very unsatisfied to very much satisfied and very much deterioration to very much improvement, respectively.

    Measured: 27 months

  4. Level of Frailty

    To measure the level of frailty and participation, the Evaluative Frailty Index is used. This questionnaire consists of 50 items on deficits in health (symptoms, signs and disabilities) in multiple domains (physical, psychological, social and general health status).

    Measured: 27 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2017
  2. Study start6 Nov 2017
  3. Primary completion4 Sep 2020
  4. Study completion4 Sep 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
stepped wedge cluster randomised trial and mixed methods process analysis
Masking
Single blind
Who is masked
Participant
Enrolment
292 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03212859
Sponsor's protocol ID
104612
Status last verified
Mar 2021
First submitted
28 Jun 2017
Last updated
17 Mar 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Heij W, Sweerts L, Staal JB, Teerenstra S, Adang E, van der Wees PJ, Nijhuis-van der Sanden MWG, Hoogeboom TJ. Implementing a Personalized Physical Therapy Approach (Coach2Move) Is Effective in Increasing Physical Activity and Improving Functional Mobility in Older Adults: A Cluster-Randomized, Stepped Wedge Trial. Phys Ther. 2022 Dec 6;102(12):pzac138. doi: 10.1093/ptj/pzac138.

    PubMed 36200397
  • Heij W, Teerenstra S, Sweerts L, Staal JB, Nijhuis-van der Sanden MWG, Hoogeboom TJ. Implementation of a Cost-Effective Physical Therapy Approach (Coach2Move) to Improve Physical Activity in Community-Dwelling Older Adults With Mobility Problems: Protocol for a Cluster-Randomized, Stepped Wedge Trial. Phys Ther. 2020 Apr 17;100(4):653-661. doi: 10.1093/ptj/pzz183.

    PubMed 31846501

Questions about this trial

What is this clinical trial studying?

A study testing Coach2Move in people with Sedentary Lifestyle and Physical Activity, run by Radboud University Medical Center at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-reported Physical Activity (time frame: 27 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03212859, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Mar 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in